This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA economists summarize the key points discussed in MOFCOM’s announcement regarding the economic analyses it considered in evaluating Thermo Fisher Scientific’s $13.5 billion acquisition of Life Technologies Corp.
Is it a good business strategy for a creator of new technology to make that technology available to other companies in the industry, including its competitors?...
China has become a major jurisdiction for resolving global standard essential patent (SEP) disputes, with its courts now open to global rate-setting, anti-suit...
Sean May is a panelist on “Viewing Hospital and Physician Mergers from Two Sides.” The session covers: Key evidence used to evaluate competitive harm from...
CRA is a proud sponsor of this event. Raphael De Coninck is a panelist during the first webinar session on May 25th titled “The Value of IP: Frand Licensing of...
